Refined high-content imaging-based phenotypic drug screening in zebrafish xenograftsCaterina Sturtzel, Martin Distel|npj Precision Oncology|2023Cited by 44
A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in VivoSusana Pascoal, Martin Distel|Cancers|2020Cited by 35
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Andrea Bileck et al.|Cancer Research|2023Cited by 24
Automated compound testing in zebrafish xenografts identifies combined MCL-1 and BCL-X <sub>L</sub> inhibition to be effective against Ewing sarcomaSarah Grissenberger, Martin Distel|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0
Suppl. Figure S14 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Corinne I. Stoffel et al.|Unknown|2023Cited by 0